Boston Scientific Corporation (BSX)’s Long Road to Respectability Begins
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 29, 2013 - 4:12pm
Investors in troubled medical device maker Boston Scientific Corporation (NYSE:BSX) have been waiting for the flickers of hope in a turnaround for some time. With the company’s cardiac rhythm management, or CRM, business in retreat, the outlook hasn’t been pretty over the recent past; however, things have finally started to look up for this company. Shares [...]
Continue reading this article »Share This Article: